Schaefer Advertising
Independent
Address
1228 S Adams St
Fort Worth, Texas 76104
Web Address
Year Founded
1995
Full-time Employees
37
Number of Clients
17
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
1
Locations
Fort Worth, TX
Executives & Senior Management
Ken Schaefer
President/Owner
Sara Hull
EVP Account Strategy & Client Development
Jake Yarbrough
Managing Director Healthcare
Senior Management
Ken Schaefer
President/Owner
Sara Hull
EVP Account Strategy & Client Development
Charlie Howlett
VP Creative Director
Debbie Carrell
VP Controller
Jake Yarbrough
Managing Director Healthcare
Doug Austin
VP Growth and Innovation
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Payer
Med-Tech
Public Health
Data/Analytics
Digital
New Services
n/a
Client Roster
GALDERMA - Aklief
GALDERMA - Twyneo
GALDERMA - Oracea
GALDERMA - Epsolay
GALDERMA - Tri-Luma
GALDERMA - GCC
GALDERMA - Mirvaso
GALDERMA - Soolantra
GALDERMA - Cetaphil
GALDERMA - Epiduo Forte
SIGHT SCIENCES - TearCare
SIGHT SCIENCES - OMNI Surgical System
Podimetrics
Argon Medical Devices, Inc.
Argon CPS
Cleaner Plus
Argon Biopsy
Argon Drainage Products
TearLab
University of North Texas Health Science Center
Moncrief Cancer Institute
Texas Health Advent — Texas Health Huguley
Texas Health Advent — Texas Health Mansfield
NCODA
Eosera
OptMyCare
Growth
2021 Growth from Existing Clients
25%
2021 Growth from New Clients
75%
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Managing growth
Payer-related challenges
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Replenishing new-business pipeline
Further diversification of services
Regulatory concerns
Competition from consultancies and other non-traditional organizations
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Ongoing fallout from pandemic
Creative Samples
